References
- 1. Hulsmeyer M, Hillig RC, Volz A, Ruhl M, Schroder W, Saengen W, et al. HLA-B27 Subtypes differentially associated with disease exhibit subtle structural alterations. J Biol Chem. 2002; 227(49): 47844-47853.
- 2. Popa OM, Bojinica M, Bojinica V, Ciofu C, Dutescu MI, Bardan A, et al.Distribution of HLAB27 in Romanian spondyloarthritides patients. Int J Immunogenet. 2010; 37(6): 513-516.
- 3. Colbert RA, DeLay ML, Layh-Schmitt G, Sowders DP. HLA-B27 misfolding and spondyloarthropathies. Prion. 2009; 3(1): 15-26.
- 4. Bowness P. HLA B27 in health and disease: a double-edged sword? Rheumatology. 2002; 41(8): 857-868.
- 5. Huhtinen M. Acute anterior uveitis and HLAB27: infectious background, systemic inflamation and prognosis of the patients. Academic dissertation, defended at the Medical Faculty of the University of Helsinki, Helsinki, 2002.
- 6. Allen RL, Bowness P, McMichael AJ. The role of HLA-B27 in spondyloarthritis. Immunogenetics. 1999; 50(3-4): 220-227.
- 7. Marsh SGE. Nomenclature for factors of the HLA system, update September 2011. Int J Immunogenet. 2011; 39(1): 95-97.
- 8. Khan MA. Recent advances in the genetics of ankylosing spondylitis. Future Rheumatol. 2008; 3(5): 403-405.
- 9. Cauli A, Dessole G, Fiorillo MT, Vacca A, Mameli A, Bitti P, et al. Increased level of HLA B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease. Rheumatology. 2002; 41(12): 1375-1379.
- 10. Vartdal F, Gaudernack G, Funderud S, Bratlie A, Lea T, Ugelstad J, et al. HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation-a fast and reliable technique. Tissue Antigens. 1986; 25(5): 301-312.
- 11. Vartdal F, Bratlie A, Gaudernack G, Funderud S, Lea T, Thorsby E. Microcytotoxic HLA typing of cells directly isolated from blood by means of antibody-coated microspheres. Transplant Proceedings. 1987; 19(1): 655-657.
- 12. Walker RH. Technical Manual, 11th ed. Bethesda: American Association of Blood Banks, 1993: 305-307.
- 13. Stites DP, Stobo JD, Wells JV. Osnovna i klinička imunologija. Beograd: Savremena Administracija, 1989; 50-63.
- 14. Svejgaard A, Platz R, Ryder LP. HLA and disease 1982-A survey. Immunolog Rev. 1983; 70(1): 193-201.
- 15. Bengston BO, Thompson G. Measuring the strength of associations between HLA antigens and disease. Tissue Antigens. 1981; 18(5): 356-363.
- 16. Green A. The epidemiologic approach to studies of association between HLA and disease.II Estimation of absolute risk, etiologic and preventive fraction. Tissue Antigens. 1982; 19(4): 259-168.
- 17. Petz B. Osnovne statističke metode. Zagreb: Izdanja škole narodnog zdravlja “Andrija Štampar.” 1967: 111-134.
- 18. Snedecor GW, Cochan GW. Statistical Methods. Ames: The Iowa State University Press. 1956: 219-221.
- 19. Emam SJ, Badri S, Bayat A, Dashtebozorg N, Khosravi A. Evaluation of 278 HLA-B27 positive patients suspected of seronegative spondyloarthropathies. Pakistan J Med Sci. 2007; 23(5): 728-732.
- 20. McMichael A, Bowness P. HLA-B27:natural function and pathogenic role in spondyloarthritis. Arthritis Res. 2002; 4(Suppl 3): S153-S158.
- 21. Sahin S, Aydogan L, Benli I, Ozyurt H. Distribution of HLA-B27 and CYP2D6*4 mutations in the middle Black Sea area (Tokat) of Turkey. Genet Molec Res. 2011; 10(4): 3987-3991.
- 22. Sheehan NJ. The ramifications of HLA-B27. J Roy Soc Med. 2004; 97(1): 10-14.
- 23. Dhurandhar PS, Shankarkumar U. HLA Association in seronegative spondyloarthritis patients from Mumbai, India. Int J Hum Genet. 2007; 7(3): 235-239.
- 24. Pitchappan RM, Balakrlshnan K, Mahendran V, Brahmajathi V. HLA and disease susceptibility in Tamil Nadu, S. India. Indian J Hum Genet. 1995; 1(1):56-62.
- 25. Kim T-H, Uhm W-S, Inman RD. Pathogenesis of ankylosing spondylitis and reactive arthritis. Curr Opin Rheumatol. 2005; 17(4): 400-405.
- 26. Colmegna I, Cuchacovich R, Espinoza LR. HLA- B27 associated reactive arthritis: pathogenetic and clinical considerations. Clin Microbiol Rev. 2004; 17(2): 348-369.
- 27. Carter JD, Hudson AP. Reactive arthritis: clinical aspects and medical management. Rheumatic Dis Clin North Am. 2009; 35(1): 21-44.
- 28. FitzGerald O, Winchester R. Psoriatic arthritis: from pathogenesis to therapy. Arthritis Res Ther. 2009; 11(1): 214-223.
- 29. Khairallah M,Yahia SB, Ladjimi A, Messaoud R, Zaouali S, Attia S, et al. Pattern of uveitis in a referral centre in Tunisia, North Africa. Eye. 2007; 21(1): 33-39.
- 30. Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27: what’s new? In: Pleyer U, Forrester JV, Eds. Uveitis and Immunological Disorders. Heidelberg: Springer- Verlag. 2009:9-17.
- 31. Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27. Survey Ophtalmol. 2005; 50(4): 364-388.
- 32. Mishra MN, Bharucha KM. HLA-B27 Association with uveitis in an Asian Indian population. Iranian J Immunol. 2011; 8(2): 85-89.